Actively Recruiting
Follow-Up Imaging Study of Patients with Hypertrophic Cardiomyopathy from the HCMR Cohort Evaluating Late Gadolinium Enhancement and Heart Risk
Led by Christopher Kramer · Updated on 2026-10-16
314
Participants Needed
8
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying people with hypertrophic cardiomyopathy HCM, a genetic condition that thickens the heart muscle and affects its function and electrical system. The study aims to understand what might predict heart problems, such as sudden death from fast heart rhythms or heart failure, particularly focusing on a substance called late gadolinium enhancement LGE found in heart muscle from previous MRI scans. This observational study follows participants from an earlier research project called HCMR - Novel Predictors of Outcome in Hypertrophic Cardiomyopathy. Participants in this study are those who were part of the original HCMR group and will undergo follow-up imaging to observe how LGE changes over time. The study groups include people with obstructive and non-obstructive forms of HCM, with specific criteria for heart function and other health factors. No new treatments or drugs are given, as this is an observational study focusing on imaging and monitoring. Throughout the study, participants will have imaging tests to measure changes in the percentage of LGE mass in their hearts over at least seven years. The study tracks these changes to better understand risks associated with HCM. Participants will be monitored without receiving any experimental treatment, and the research team will use these imaging results to learn more about the conditions progression. The study is planned to continue until 2028.
CONDITIONS
Brief Title
HCMR Re-Imaging Study
Research Team
G
Gina Duda
T
Thuy Le
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here